Evaluation of the Safety and Effectiveness of Nevirapine Plus Coformulated Tenofovir/Emtricitabine as First-Line Therapy in Routine Clinical PracticeVALLECILLO, Gabriel; DOMINGO, Pere; MALLOLAS, Josep et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 165-170, issn 0889-2229, 6 p.Article

Microdetermination of Emtricitabine in Human Plasma by Liquid Chromatography/Tandem Mass SpectrometryYADAV, Manish; SINGHAL, Puran; GOSWAMI, Sailendra et al.Journal of AOAC International. 2009, Vol 92, Num 6, pp 1681-1689, issn 1060-3271, 9 p.Article

Bioequivalence of efavirenz /emtricitabine /tenofovir disoproxil fumarate single-tablet regimenMATHIAS, Anita A; HINKLE, John; MENNING, Mark et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 167-173, issn 1525-4135, 7 p.Article

Pharmacokinetics of emtricitabine, tenofovir, and GS-9137 following coadministration of emtricitabine/tenofovir disoproxil fumarate and ritonavir-boosted GS-91 37RAMANATHAN, Srinivasan; GONG SHEN; CHENG, Andrew et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 3, pp 274-279, issn 1525-4135, 6 p.Article

Emtricitabine (FTC) for the treatment of HIV infectionNELSON, M; SCHIAVONE, M.International journal of clinical practice (Esher). 2004, Vol 58, Num 5, pp 504-510, issn 1368-5031, 7 p.Article

Tenofovir Disoproxil Fumarate, Emtricitabine, and Efavirenz Compared With Zidovudine/Lamivudine and Efavirenz in Treatment-Naive Patients : 144-Week AnalysisARRIBAS, Jose R; POZNIAK, Anton L; TOOLE, John J et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 1, pp 74-78, issn 1525-4135, 5 p.Article

Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibilityROSS, Lisa L; PARKIN, Neil; GERONDELIS, Peter et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 5, pp 567-570, issn 1525-4135, 4 p.Article

Prospective randomized trial of emtricitabine versus lamivudine short-term monotherapy in human immunodeficiency virus-infected patientsROUSSEAU, Franck S; WAKEFORD, Charles; MOMMELA-MARIN, Herve et al.The Journal of infectious diseases. 2003, Vol 188, Num 11, pp 1652-1658, issn 0022-1899, 7 p.Article

Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen: A Review of Its Use in HIV InfectionDEEKS, Emma D.Drugs (Basel). 2014, Vol 74, Num 17, pp 2079-2095, issn 0012-6667, 17 p.Article

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/ lamivudine + efavirenz administered on a multiple tablet therapyBLANCO, José L; MONTANER, Julio S. G; PERNO, Carlo F et al.AIDS (London). 2014, Vol 28, Num 17, pp 2531-2539, issn 0269-9370, 9 p.Article

Maraviroc Once-Daily Nucleoside Analog-Sparing Regimen in Treatment-Naive Patients: Randomized, Open-Label Pilot StudyMILLS, Anthony; MILDVAN, Donna; HEERA, Jayvant et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 2, pp 164-170, issn 1525-4135, 7 p.Article

En bref : Truvada pour la prévention du VIH = In Brief: Truvada for HIV PreventionThe Medical letter on drugs and therapeutics (Edition française). 2012, Vol 34, Num 18, issn 0253-8512, p. 69Article

Characterization of Peripheral and Mucosal Immune Responses In Rhesus Macaques on Long-Term Tenofovir and Emtricitabine Combination Antiretroviral TherapyJASNY, Edith; GEER, Suzanne; ROBBIANI, Melissa et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 4, pp 425-435, issn 1525-4135, 11 p.Article

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet for HIV-I Infection TreatmentOLIN, Jacqueline L; SPOONER, Linda M; KLIBANOV, Olga M et al.The Annals of pharmacotherapy. 2012, Vol 46, Num 12, pp 1671-1677, issn 1060-0280, 7 p.Article

Four year follow-up of simplification therapy with once-daily emtricitabine, didanosine and efavirenz in HIV-infected patients (ALIZE ANRS 099 trial)GALLIEN, Sébastien; JOURNOT, Valérie; CHENE, Geneviève et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 1, pp 184-191, issn 0305-7453, 8 p.Article

Managing hepatitis B/HIV co-infected: adding entecavir to truvada (tenofovir disoproxil/ emtricitabine) experienced patientsRATCLIFFE, Libuse; BEADSWORTH, Michael B. J; PENNELL, Ashley et al.AIDS (London). 2011, Vol 25, Num 8, pp 1051-1056, issn 0269-9370, 6 p.Article

Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/ TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver DiseaseLIAW, Yun-Fan; SHEEN, I-Shyan; BUTI, Maria et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 1, pp 62-72, issn 0270-9139, 11 p.Article

Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistanceAIDS (London). 2010, Vol 24, Num 16, pp 2481-2488, issn 0269-9370, 8 p.Article

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabineMANSOUR, Wael; DUCANCELLE, Alexandra; LE GAL, Frederic et al.Journal of clinical virology. 2010, Vol 47, Num 1, pp 97-99, issn 1386-6532, 3 p.Article

A Randomized Comparative Trial of Continued Zidovudine/Lamivudine or Replacement With Tenofovir Disoproxil Fumarate/Emtricitabine in Efavirenz-Treated HIV-1-Infected IndividualsFISHER, Martin; MOYLE, Graeme J; SHAHMANESH, Mohsen et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 5, pp 562-568, issn 1525-4135, 7 p.Article

Development of HIV-1 Drug Resistance Through 144 Weeks in Antiretroviral-Naïve Subjects on Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz Compared With Lamivudine/Zidovudine and Efavirenz in Study GS-01-934MARGOT, Nicolas A; ENEJOSA, Jeff; CHENG, Andrew K et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 209-221, issn 1525-4135, 13 p.Article

Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistanceFURCO, André; GOSRANI, Bhairvi; KAPEMBWA, Moses et al.AIDS (London). 2009, Vol 23, Num 3, pp 434-435, issn 0269-9370, 2 p.Article

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/ emtricitabine with lopinavir/ritonavir for initial HIV treatmentSMITH, Kimberly Y; PATEL, Parul; WANNAMAKER, Paul et al.AIDS (London). 2009, Vol 23, Num 12, pp 1547-1556, issn 0269-9370, 10 p.Article

Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1―Infected PatientsDEJESUS, Edwin; YOUNG, Benjamin; MCCOLL, Damian et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 51, Num 2, pp 163-174, issn 1525-4135, 12 p.Article

Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week TrialMARTIN, Allison; BLOCH, Mark; AMIN, Janaki et al.Clinical infectious diseases. 2009, Vol 49, Num 10, pp 1591-1601, issn 1058-4838, 11 p.Article